Welcome to our dedicated page for NSTG news (Ticker: NSTG), a resource for investors and traders seeking the latest updates and insights on NSTG stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NSTG's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NSTG's position in the market.
NanoString Technologies (NASDAQ:NSTG) announced it will release its third quarter 2021 operating results after market close on November 9, 2021. A conference call will be held at 4:30pm ET to discuss the results and provide a business update. Interested parties should register in advance for the call at this link. A replay will be available from November 9, 2021 at 7:30pm ET through November 16, 2021.
NanoString is known for its nCounter Analysis System used for gene and protein profiling.
NanoString Technologies, Inc. (NASDAQ:NSTG) will webcast a presentation at the Baird 2021 Global Healthcare Conference on September 14, 2021, at 5:30 PM ET. CEO Brad Gray will lead the presentation, which can be accessed live from the investor section of their website. A replay will be available an hour after the event and archived for 60 days. NanoString is known for its innovative life science tools, including the nCounter® Analysis System and GeoMx® Digital Spatial Profiler, which facilitate advanced research in gene and protein profiling.
NanoString Technologies (NASDAQ:NSTG) has announced that CEO Brad Gray will present at the 19th Annual Morgan Stanley Global Healthcare Conference on September 9, 2021, at 2:45 PM ET. The live presentation will be accessible via webcast on the company's investor website. A replay will be available one hour post-presentation, archived for 60 days. NanoString is a leader in life science tools, with products like the nCounter® Analysis System and GeoMx® Digital Spatial Profiler, used for advanced genomic profiling in research.
NanoString Technologies (NASDAQ: NSTG) announced the publication of a peer-reviewed study in the journal Cell, showcasing the use of its GeoMx® Digital Spatial Profiler (DSP) in colorectal cancer research. The study, led by researchers from the Broad Institute, examined interactions between tumor and immune cells in colorectal cancer samples. Using advanced techniques, the study revealed spatial transcriptional regulation crucial for understanding immune-tumor dynamics. NanoString's DSP aids in high-throughput RNA and protein profiling, with over 60 publications validating its applications in research.
NanoString Technologies (NASDAQ:NSTG) reported Q2 2021 financial results, showcasing significant growth across its product lines. Product and service revenue increased by 59% to $33.6 million, driven by a 115% rise in consumables revenue. Instrument sales reached $11.8 million, including $7.4 million from GeoMx Digital Spatial Profilers. With a robust cash position of $398 million, the company updated its 2021 revenue outlook, anticipating $143 to $147 million in total revenue. New product launches and collaborations, including with the Parker Institute for Cancer Immunotherapy, further bolster growth prospects.
NanoString Technologies, Inc. (NASDAQ:NSTG) announced that it will release its second quarter 2021 operating results after market close on August 4, 2021. Following the announcement, management will hold a conference call at 4:30 PM ET to discuss the results and provide a business update. Investors can register for the call to receive dial-in details. A replay will be available starting August 4 at 7:30 PM ET, accessible via a dedicated phone line and the company’s website. NanoString is recognized for its nCounter® Analysis System and GeoMx™ Digital Spatial Profiler, significant tools in life sciences research.
NanoString Technologies (NASDAQ: NSTG) has launched the nCounter® Stem Cell Characterization Panel aimed at enhancing the analysis and optimization of stem cell lines for novel therapeutic development. This panel addresses critical challenges in stem cell research by providing a standardized assay that evaluates stem cell viability, functionality, and pluripotency through the measurement of eight essential components of stem cell biology. The novel panel, designed with input from experts, yields results in under 24 hours and is expected to facilitate advancements in various research areas such as neurological and cardiovascular diseases.
NanoString Technologies (NASDAQ: NSTG) is collaborating with the Parker Institute for Cancer Immunotherapy (PICI) on a project to enhance CAR-T cell therapy for solid tumors. This venture aims to standardize the characterization of cell therapies, utilizing NanoString's nCounter® Analysis System and a specialized gene expression panel. By analyzing key biological characteristics of existing therapies, the collaboration seeks to improve patient outcomes. Insights from this research will be shared publicly through PICI’s Cancer Data and Evidence Library (CANDEL) to benefit the broader scientific community.
NanoString Technologies (NASDAQ:NSTG) has announced that its management will present at the Jefferies Virtual Healthcare Conference on June 1, 2021, at 1:30 PM ET. The presentation can be accessed via a live webcast on the company's website, with a replay available after one hour and archived for 60 days. NanoString is a prominent provider of life science tools, known for its nCounter® Analysis System, used extensively in research with over 4,300 citations. Their GeoMx® Digital Spatial Profiler allows for advanced spatial profiling of RNA and protein in various sample types.
NanoString Technologies, a leader in life science tools, will present at the UBS Global Healthcare Conference on May 25, 2021, at 1:00 PM ET. CEO Brad Gray will deliver the presentation, with a live webcast accessible through the company's investor website. The event will also have a replay available for up to 60 days after the live session. Known for its nCounter Analysis System and GeoMx Digital Spatial Profiler, NanoString facilitates groundbreaking research in biomarker discovery and validation. For further details, visit www.nanostring.com.